Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01155050
Other study ID # PBRC 29032
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2010
Est. completion date December 2010

Study information

Verified date January 2024
Source Pennington Biomedical Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will assess the effect of in-home tele-health monitoring on health outcomes for LSUHCSD chronic disease, overweight or obese patients diagnosed with type II diabetes or hypertension.


Description:

This study will assess the effect of in-home tele-health monitoring on health outcomes for LSUHCSD chronic disease, overweight or obese patients diagnosed with type II diabetes or hypertension. Primary emphasis will be on assessing the effect of tele-health home monitoring combined with motivational telephone coaching on weight loss and waist circumference as compared to self-directed, home monitoring alone, and telephone coaching alone. Secondary outcomes such as blood pressure, Hemoglobin A1c (HbA1c), fasting blood sugar, and cholesterol will be examined as well.


Recruitment information / eligibility

Status Completed
Enrollment 202
Est. completion date December 2010
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 yrs old - BMI = 25 kg/m2 and waist circumference > 40 inches (men)/ 35 inches (women) - Weight = 500lbs - At least one of the following: - Fasting blood sugar > 100 mg/dL at any point and/or taking medications for diabetes And/Or - Resting blood pressure > 130/90 mm Hg at any point and/or taking medications for hypertension - Not involved in regular physical activity or weight loss management programs - Capable of being physically active - Physically able to use in-home equipment (or presence of a household member who can assist the subject in equipment use) - Currently-working conventional telephone line at primary residence - Grounded electrical power supply at primary residence - Have been in LSU HCSD system for 6 months and anticipate remaining in the LSU HCSD patient population for the next 6 months Exclusion Criteria: - A history of drug abuse in the last year, or excess alcohol consumption (40g/day)6 - Currently dieting or engaging in any activity with the goal of losing weight - Significant weight loss or weight gain in the past year (> 50 lbs) or current use of weight loss medications - History of gastrointestinal bypass or other bariatric surgery in the last 3 years - Diagnosis of congestive heart failure - Under treatment for end-stage renal disease or end-stage liver disease - History of major organ transplant - History of cancers requiring treatment in the past 5 years with anything but excellent prognosis - Current diagnosis of schizophrenia, bipolar disorder, or other psychotic disorders - Pregnant or plan on becoming pregnant in the next 12 months. - Lack support from health care provider or family members. - Current member of household participating in study - Factors that may limit adherence to intervention or affect conduct of the trial. - Unable or unwilling to communicate with staff, to provide written informed consent, or accept the randomized assignment. - Any other condition, which, in the opinion of the investigators would impede competence or compliance or possibly hinder completion of the study.

Study Design


Intervention

Device:
Tele-health Home Monitoring
Daily tele-health monitoring data will be collected from randomized participants.
Behavioral:
TrestleTree Telephone Coaching
Weekly or bi-weekly phone calls from TrestleTree health coaches with a focus on weight loss.
Device:
Tele-health Home Monitoring Plus Trestle Telephone Coaching
Daily collection of data through the tele-health home monitor and weekly or bi-weekly phone calls with a Trestletree Health Coach.

Locations

Country Name City State
United States Earl K. Long Medical Center Baton Rouge Louisiana
United States Leonard J. Chabert Medical Center Houma Louisiana
United States WO Moss Regional Medical Center Lake Charles Louisiana

Sponsors (1)

Lead Sponsor Collaborator
Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Body Weight Body weight at five-month follow-up minus baseline body weight. Body weight is measured in pounds five-month follow-up compared to baseline
Primary Change in Waist Circumference Waist circumference at five-month follow-up minus waist circumference at baseline. Waist circumference is measured in centimeters. five-month follow-up compared to baseline
Secondary Change in Systolic Blood Pressure Change is systolic blood pressure (mmHg) from baseline to five-month follow-up. Systolic blood pressure (mmHg) at five months minus systolic blood pressure at baseline.
Secondary Change in Diastolic Blood Pressure Change in diastolic blood pressure (mmHg) from baseline to follow-up. Diastolic blood pressure (mmHg) at five months minus diastolic blood pressure at baseline.
Secondary Change in HbA1c Change in HbA1c value from baseline to five-month follow-up among those completing the study through five months. five months
Secondary Change in Triglycerides Change from baseline to five month follow-up in triglyceride level. five months
Secondary Change in Total Cholesterol Change in total cholesterol level from baseline to five-month follow-up. five months
Secondary Change in Fasting Plasma Glucose Change from baseline to five-month follow-up in fasting plasma glucose level. five months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2